Direxion Daily S&P Biotech Bear 3X ETF
LABD
15 hedge funds and large institutions have $21.2M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
586% more call options, than puts
Call options by funds: $9.57M | Put options by funds: $1.4M
31% more capital invested
Capital invested by funds: $16.2M → $21.2M (+$5.03M)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
1.55% less ownership
Funds ownership: 40.36% → 38.81% (-1.6%)
12% less funds holding
Funds holding: 17 → 15 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.03M |
| 2 |
QC
Quadrature Capital
London,
United Kingdom
|
+$807K |
| 3 |
HF
HRT Financial
New York
|
+$546K |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$247K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$216K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1.74M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$985K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$444K |
| 4 |
GS
GTS Securities
Miami,
Florida
|
-$256K |
| 5 |
HT
Headlands Technologies
Chicago,
Illinois
|
-$102K |
LABD Hedge Fund Activity: Q1 2025 in Review
15 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q1 2025, worth a combined $21.2M — up 31% from $16.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of LABD and 5 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $1.03M. The largest seller was Virtu Financial, cutting an estimated $1.74M.
- 15 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q1 2025, down from 17 in Q4 2024.
- Funds reported $21.2M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q1 2025, up 31% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q1 2025 and 7 closed out, a net change of -2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q1 2025 was First Light Asset Management, an estimated $1.03M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q1 2025 was Virtu Financial, an estimated $1.74M sold.
Based on aggregated 13F filings for Q1 2025.